Dr. Reddy's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	15,368	14,654	7,107	5,779	14,852
Short-Term Investments	72,446	43,254	74,363	56,018	29,513
Cash & Short-Term Investments	87,814	57,908	81,470	61,797	44,365
Cash Growth	51.64%	-28.92%	31.84%	39.29%	28.32%
Accounts Receivable	101,219	90,420	80,298	72,485	66,764
Other Receivables	-	2,967	2,908	1,451	5,051
Receivables	101,219	93,387	83,206	73,936	71,815
Inventory	76,531	71,085	63,552	48,670	50,884
Prepaid Expenses	-	1,883	1,947	1,452	1,138
Other Current Assets	36,411	25,849	17,874	18,398	13,654
Total Current Assets	301,975	250,112	248,049	204,253	181,856
Property, Plant & Equipment	115,930	97,761	76,886	66,462	62,169
Long-Term Investments	16,368	15,202	5,255	5,362	7,986
Goodwill	12,893	11,810	4,253	4,245	4,418
Other Intangible Assets	105,059	96,803	36,951	30,849	27,246
Long-Term Accounts Receivable	-	-	-	-	54
Long-Term Deferred Tax Assets	22,436	18,508	10,774	7,196	8,204
Other Long-Term Assets	4,685	2,793	5,350	3,487	894
Total Assets	579,346	492,989	387,518	321,854	292,827
Accounts Payable	33,411	20,053	21,547	17,857	15,971
Accrued Expenses	-	43,864	40,494	38,716	36,083
Short-Term Debt	59,135	38,045	12,723	7,390	27,082
Current Portion of Long-Term Debt	-	-	-	3,800	-
Current Portion of Leases	6,003	857	1,307	1,004	1,017
Current Income Taxes Payable	4,310	3,028	2,342	2,144	1,615
Current Unearned Revenue	-	1,983	1,435	1,981	2,576
Other Current Liabilities	64,707	22,562	16,191	12,953	9,671
Total Current Liabilities	167,566	130,392	96,039	85,845	94,015
Long-Term Debt	12,203	3,800	3,800	-	3,800
Long-Term Leases	-	4,064	2,190	1,278	1,946
Long-Term Unearned Revenue	-	1,162	1,193	1,555	1,597
Long-Term Deferred Tax Liabilities	15,568	14,108	909	833	60
Other Long-Term Liabilities	3,552	2,297	2,837	1,352	882
Total Liabilities	198,889	155,823	106,968	90,863	102,300
Common Stock	835	834	834	833	832
Additional Paid-In Capital	11,364	11,133	10,765	9,688	9,280
Retained Earnings	351,984	315,793	265,910	216,479	176,467
Treasury Stock	-1,815	-2,264	-991	-1,269	-1,601
Comprehensive Income & Other	14,695	7,892	4,032	5,260	5,549
Total Common Equity	377,063	333,388	280,550	230,991	190,527
Minority Interest	3,394	3,778	-	-	-
Shareholders' Equity	380,457	337,166	280,550	230,991	190,527
Total Liabilities & Equity	579,346	492,989	387,518	321,854	292,827
Total Debt	77,341	46,766	20,020	13,472	33,845
Net Cash (Debt)	10,473	11,142	61,450	48,325	10,520
Net Cash Growth	-6.00%	-81.87%	27.16%	359.36%	146.66%
Net Cash Per Share	12.57	13.36	73.72	58.09	12.65
Filing Date Shares Outstanding	833.71	832	832.64	830.78	829.79
Total Common Shares Outstanding	833.71	832	832.64	830.78	829.79
Working Capital	134,409	119,720	152,010	118,408	87,841
Book Value Per Share	452.27	400.71	336.94	278.04	229.61
Tangible Book Value	259,111	224,775	239,346	195,897	158,863
Tangible Book Value Per Share	310.79	270.16	287.45	235.80	191.45
Land	-	4,156	4,224	4,234	4,154
Buildings	-	28,335	27,992	26,519	24,663
Machinery	-	125,303	117,082	107,205	95,100
Construction In Progress	-	24,837	14,462	9,956	13,305

Source: S&P Global Market Intelligence. Standard template. Financial Sources.